AU Patent

AU2008268409B2 — Compositions comprising tryptophan hydroxylase inhibitors

Assigned to Lexicon Pharmaceuticals Inc · Expires 2013-12-05 · 12y expired

What this patent protects

Methods and compositions comprising tryptophan hydroxylase inhibitors are disclosed. Particular methods are directed at reducing or avoiding serotonin-mediated adverse effects associated with some drugs.

USPTO Abstract

Methods and compositions comprising tryptophan hydroxylase inhibitors are disclosed. Particular methods are directed at reducing or avoiding serotonin-mediated adverse effects associated with some drugs.

Drugs covered by this patent

Patent Metadata

Patent number
AU2008268409B2
Jurisdiction
AU
Classification
—
Expires
2013-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Lexicon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.